HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aveeno Lines Face Class Actions Over “Naturals” Claims

This article was originally published in The Tan Sheet

Executive Summary

J&J’s Aveeno brand is the focus of pending class-action suits in Connecticut that question claims for the brand’s sunscreen and baby wash lines and a suit in New York about the Active Naturals personal care line. The complaints allege Aveeno liberally uses the term “natural” for its products that contain a number of synthetic ingredients.

You may also be interested in...



J&J Settles Class Action For “Misleading” Neutrogena Naturals Claims

The case hinges on claims used to promote Neutrogena Naturals cleansers and moisturizers – specifically, that they are “natural products that contain no petrochemicals,” according to court documents. The consumer plaintiffs say they paid a premium over “comparable products” on the basis of those claims.

Merck Faces Consumer Suit Over Coppertone UV Claims

A lawsuit filed in federal court in New Jersey alleges Merck has misrepresented the UV-protective benefits of its Coppertone sunscreen products, subjecting consumers to potential risks.

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124045

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel